ANSM — authorised 12 April 2006
- Marketing authorisation holder: SANDOZ GMBH
- Status: approved
ANSM authorised Omnitrope on 12 April 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. ANSM authorised it on 12 April 2006.
SANDOZ GMBH holds the French marketing authorisation.